Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Clinical Trial of Recombinant Human Interferon Gamma (Ingaron) in Pulmonary Tuberculosis

NCT06118619 is registered in ClinicalTrials.gov with SPP Pharmaclon Ltd. as lead sponsor.

NCT NCT06118619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06118619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Clinical Trial of Recombinant Human Interferon Gamma (Ingaron) in Pulmonary Tuberculosis
Lead sponsor
SPP Pharmaclon Ltd.
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
March 1, 2024
Enrollment
350 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tuberculosis